Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Softcat raises profit guidance after strong third quarter

(Sharecast News) - IT infrastructure group Softcat has raised its guidance for full-year profit growth after a stronger-than-expected third-quarter performance. The firm, which provides things like cloud, cybersecurity and connectivity solutions, said it performed well during the three months to 30 April, with double-digit growth in gross profit and operating profit over last year.

That followed 12.1% and 10.4% growth in the respective measures in the first half, which Softcat reported in March was ahead of its expectations.

In a short trading update on Wednesday, the company said that growth was "broad-based across technology areas and customer segments" during the third-quarter period.

Its performance was also supported by the conversion of some larger solutions projects.

"The board is pleased with progress to date and, reflecting the contribution from larger deals, now expects low-teens growth in operating profit for the full year, up from low double-digit previously," Softcat said.

Shares were up 2.1% at 1,818p in early deals.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.